English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Publisher's Note: "Data-driven equation for drug-membrane permeability across drugs and membranes" [J. J. chem. Phys. 154, 244114 (2021)]

MPS-Authors

Dutta,  Arghya
MPI for Polymer Research, Max Planck Society;

/persons/resource/persons21549

Ghiringhelli,  Luca M.
NOMAD, Fritz Haber Institute, Max Planck Society;

Bereau,  Tristan
MPI for Polymer Research, Max Planck Society;
Van ’t Hoff Institute for Molecular Sciences and Informatics Institute, University of Amsterdam;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

5.0061875.pdf
(Publisher version), 3MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Dutta, A., Vreeken, J., Ghiringhelli, L. M., & Bereau, T. (2021). Publisher's Note: "Data-driven equation for drug-membrane permeability across drugs and membranes" [J. J. chem. Phys. 154, 244114 (2021)]. The Journal of Chemical Physics, 155(3): 039901. doi:10.1063/5.0061875.


Cite as: https://hdl.handle.net/21.11116/0000-0008-F549-2
Abstract
Drug efficacy depends on its capacity to permeate across the cell membrane. We consider the prediction of passive drug-membrane permeability coefficients. Beyond the widely recognized correlation with hydrophobicity, we apply sure-independence screening and sparsifying operator (SISSO), a data-driven compressed-sensing technique, to a large (0.4 million compounds) database of coarse-grained computer simulations as a way to also incorporate the role of acidity. We rationalize our derived equation by means of an analysis of the inhomogeneous solubility-diffusion model in several asymptotic acidity regimes. We further extend our analysis to the dependence on lipid-membrane composition. Lipid-tail unsaturation plays a key role: we report a permeability ratio between liquid-disordered (Ld) and liquid-ordered (Lo) domains of roughly 25, largely independent of the chemistry of the drug. They confirm the role of membrane surface-density fluctuations in passive permeation. Together, compressed sensing with analytically derived asymptotes establish and validate an accurate, broadly applicable, and interpretable equation for passive permeability across both drug and lipid-tail chemistry.